Healthcare provider profile · identity verified

Jackie E. Mchenry, M.D.

Family Practice · CALHOUN CITY, MS · NPI 1649252057

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	471	39
Atorvastatin Calcium	Atorvastatin Calcium	470	76
Eliquis	Apixaban	404	33
Amlodipine Besylate	Amlodipine Besylate	378	74
Furosemide	Furosemide	277	49
Donepezil Hcl	Donepezil Hcl	235	28
Memantine Hcl	Memantine Hcl	208	28
Tamsulosin Hcl	Tamsulosin Hcl	203	36
Carvedilol	Carvedilol	185	26
Metformin Hcl	Metformin Hcl	177	35
Losartan Potassium	Losartan Potassium	173	39
Pravastatin Sodium	Pravastatin Sodium	141	27
Famotidine	Famotidine	137	19
Lisinopril	Lisinopril	128	24
Metoprolol Succinate	Metoprolol Succinate	127	33
Trazodone Hcl	Trazodone Hcl	113	23
Meloxicam	Meloxicam	105	24
Pantoprazole Sodium	Pantoprazole Sodium	102	29
Buspirone Hcl	Buspirone Hcl	98	14
Gabapentin	Gabapentin	98	33
Montelukast Sodium	Montelukast Sodium	92	14
Potassium Chloride	Potassium Chloride	92	31
Metoprolol Tartrate	Metoprolol Tartrate	91	19
Duloxetine Hcl	Duloxetine Hcl	89	suppressed
Clopidogrel	Clopidogrel Bisulfate	87	20
Hydrochlorothiazide	Hydrochlorothiazide	87	24
Allopurinol	Allopurinol	79	13
Jardiance	Empagliflozin	78	suppressed
Baclofen	Baclofen	77	12
Omeprazole	Omeprazole	77	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	76	30
Escitalopram Oxalate	Escitalopram Oxalate	71	12
Levetiracetam	Levetiracetam	71	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	71	16
Mirtazapine	Mirtazapine	67	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	66	12
Tizanidine Hcl	Tizanidine Hcl	66	19
Hydralazine Hcl	Hydralazine Hcl	65	suppressed
Lactulose	Lactulose	63	suppressed
Sertraline Hcl	Sertraline Hcl	62	suppressed
Fluticasone Propionate	Fluticasone Propionate	61	16
Benztropine Mesylate	Benztropine Mesylate	60	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	56	13
Isosorbide Dinitrate	Isosorbide Dinitrate	55	suppressed
Simvastatin	Simvastatin	55	11
Lubiprostone	Lubiprostone	53	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	50	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	50	suppressed
Xarelto	Rivaroxaban	50	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	suppressed
Ondansetron Hcl	Ondansetron Hcl	48	17
Divalproex Sodium	Divalproex Sodium	46	suppressed
Clonidine Hcl	Clonidine Hcl	45	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	44	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	suppressed
Brilinta	Ticagrelor	43	suppressed
Citalopram Hbr	Citalopram Hydrobromide	42	12
Dapagliflozin	Dapagliflozin Propanediol	42	suppressed
Ozempic	Semaglutide	39	12
Sucralfate	Sucralfate	39	suppressed
Atenolol	Atenolol	37	suppressed
Trintellix	Vortioxetine Hydrobromide	37	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	36	14
Alendronate Sodium	Alendronate Sodium	36	suppressed
Spironolactone	Spironolactone	36	suppressed
Lovastatin	Lovastatin	35	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Aripiprazole	Aripiprazole	32	suppressed
Tradjenta	Linagliptin	32	suppressed
Diltiazem Hcl	Diltiazem Hcl	31	suppressed
Alprazolam	Alprazolam	30	suppressed
Metformin Hcl Er	Metformin Hcl	28	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Amiodarone Hcl	Amiodarone Hcl	26	suppressed
Carbamazepine	Carbamazepine	26	suppressed
Finasteride	Finasteride	26	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	26	suppressed
Solifenacin Succinate	Solifenacin Succinate	26	suppressed
Alogliptin	Alogliptin Benzoate	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	11
Glimepiride	Glimepiride	25	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	25	suppressed
Lamotrigine	Lamotrigine	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	21
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Methenamine Hippurate	Methenamine Hippurate	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Olanzapine	Olanzapine	21	suppressed
Topiramate	Topiramate	21	suppressed
Latanoprost	Latanoprost	20	suppressed
Methotrexate	Methotrexate Sodium	20	suppressed
Clindamycin Hcl	Clindamycin Hcl	19	15
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Ranolazine Er	Ranolazine	19	suppressed
Doxepin Hcl	Doxepin Hcl	18	suppressed
Naproxen	Naproxen	18	11
Risperidone	Risperidone	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Primidone	Primidone	17	suppressed
Azithromycin	Azithromycin	16	11
Farxiga	Dapagliflozin Propanediol	16	suppressed
Raloxifene Hcl	Raloxifene Hcl	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	11
Insulin Lispro Kwikpen U-100	Insulin Lispro	15	suppressed
Lagevrio (Eua)	Molnupiravir	15	15
Mupirocin	Mupirocin	15	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	15	suppressed
Prednisone	Prednisone	15	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	14	suppressed
Calcitriol	Calcitriol	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Promethazine Hcl	Promethazine Hcl	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	14	suppressed
Valsartan	Valsartan	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Xifaxan	Rifaximin	14	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	13	suppressed
Levemir	Insulin Detemir	13	suppressed
Norethindrone-E.Estradiol-Iron	Norethindrone-E.Estradiol-Iron	13	suppressed
Nystatin	Nystatin	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	13	suppressed
Anastrozole	Anastrozole	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Cilostazol	Cilostazol	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	12	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	12	suppressed
Invega Sustenna	Paliperidone Palmitate	12	suppressed
Levofloxacin	Levofloxacin	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Rivastigmine	Rivastigmine	12	suppressed
Vilazodone Hcl	Vilazodone Hcl	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Diazepam	Diazepam	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Tamoxifen Citrate	Tamoxifen Citrate	11	suppressed
Tramadol Hcl	Tramadol Hcl	11	suppressed
Victoza 3-Pak	Liraglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error